Skip to main content
logo
TTY Biopharm Company Limited (TPEX:4105)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
73.40
+0.40 (0.55%)
May 29, 2026, 1:30 PM CST

Revenue by Segment

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Other Department
21.92M35.23M65.44M106.64M270.72M
Other Department Growth
-37.78%-46.16%-38.64%-60.61%38.09%
Anti-infection medicine segment
1.50B1.32B1.20B899.62M1.14B
Anti-infection medicine segment Growth
13.80%9.41%33.77%-20.80%14.79%
Cancer Drug Business Group
2.50B2.46B2.43B2.34B2.77B
Cancer Drug Business Group Growth
1.65%1.41%3.78%-15.44%6.18%
Reinvestment Segment
1.43B1.24B814.45M747.28M-
Reinvestment Segment Growth
15.55%51.71%8.99%--
Healthcare Business Group
263.43M262.41M195.63M581.66M221.48M
Healthcare Business Group Growth
0.39%34.14%-66.37%162.62%4.16%
Export and OEM Group
1.25B1.02B796.70M653.68M-
Export and OEM Group Growth
22.00%28.55%21.88%--
Adjustments and Eliminations
-512.98M-444.41M--268.62M-274.72M
Cardiovascular and Gastrointestinal Drugs Business Group
----413.48M
Cardiovascular and Gastrointestinal Drugs Business Group Growth
-----7.68%
Total
6.45B5.89B5.51B5.06B4.54B
Total Growth
9.49%7.05%8.77%11.60%7.43%

Revenue by Geography

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Taiwan
5.49B5.12B4.84B4.60B4.25B
Taiwan Growth
7.22%5.78%5.24%8.33%8.01%
America
557.54M381.29M265.71M59.43M-
America Growth
46.22%43.50%347.07%--
Other Countries
405.11M391.78M398.66M402.12M289.25M
Other Countries Growth
3.40%-1.73%-0.86%39.02%4.04%
Total
6.45B5.89B5.51B5.06B4.54B
Total Growth
9.49%7.05%8.77%11.60%7.43%
Source: S&P Global Market Intelligence.